Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials.

MLA

Glatz, Torben, et al. “Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials.” Journal of Clinical Medicine, vol. 9, no. 8, Aug. 2020, p. 2654. EBSCOhost, https://doi.org/10.3390/jcm9082654.

APA

Glatz, T., Verst, R., Kuvendjiska, J., Bronsert, P., Becker, H., Hoeppner, J., & Kulemann, B. (2020). Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials. Journal of Clinical Medicine, 9(8), 2654. https://doi.org/10.3390/jcm9082654

Chicago

Glatz, Torben, Rasmus Verst, Jasmina Kuvendjiska, Peter Bronsert, Heiko Becker, Jens Hoeppner, and Birte Kulemann. 2020. “Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials.” Journal of Clinical Medicine 9 (8): 2654. doi:10.3390/jcm9082654.